Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outline
Trial Contact Information
Registry Information
Study of Decision Making in Patients Participating in Phase I Clinical Trials
| Phase | Type | Status | Age | Sponsor | Protocol IDs |
|---|---|---|---|---|---|
| No phase specified | Educational/Counseling/Training | Active | 18 and over | NCI | NCI-03-C-0063 NCT00054223 |
Special Category: NIH Clinical Center trial
Objectives
- Determine the range of personality traits of patients enrolled in a phase I clinical trial.
- Determine these patients' understanding of their medical situation and prognosis.
- Determine these patients' understanding of risks and benefits of phase I clinical trials.
- Determine these patients' reasons for participating in a phase I clinical trial.
- Determine the risk/benefit trade-offs of these patients.
- Determine the existential outlook of these patients.
- Determine the information gathering nature of these patients.
Entry Criteria
Disease Characteristics:
- Consented to enrollment in a phase I cancer clinical trial
Prior/Concurrent Therapy:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Not specified
Other
- No concurrent enrollment in other clinical trials evaluating phase I patient attitudes
Patient Characteristics:
Age
- 18 and over
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- Understands written English
Expected Enrollment
250Approximately 250 patients will be accrued for this study within 6 months.
Outline
This is a multicenter study.
Before beginning phase I clinical trial treatment, patients complete a survey over 30-45 minutes administered by an interviewer. Patients then self-administer the Temperament and Character Inventory assessment over 30 minutes.
Trial Lead Organizations
NCI - Center for Cancer Research
| Manish Agrawal, MD, Protocol chair |
| |||
| U.S.A. | |||||||
| Illinois | |||||||
| Chicago | |||||||
| Robert H. Lurie Comprehensive Cancer Center at Northwestern University | |||||||
| Clinical Trials Office - Robert H. Lurie Comprehensive Cancer Center at Northwestern University |
| ||||||
| Email: cancer@northwestern.edu | |||||||
| Maryland | |||||||
| Bethesda | |||||||
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | |||||||
| Contact Person |
| ||||||
| Pennsylvania | |||||||
| Philadelphia | |||||||
| Fox Chase Cancer Center - Philadelphia | |||||||
| Clinical Trials Office - Fox Chase Cancer Center - Philadelphia |
| ||||||
| Texas | |||||||
| Houston | |||||||
| M. D. Anderson Cancer Center at University of Texas | |||||||
| Clinical Trials Office - M. D. Anderson Cancer Center at the University of Texas |
| ||||||
| San Antonio | |||||||
| Cancer Therapy and Research Center | |||||||
| Clinical Trials Office - Cancer Therapy and Research Center |
| ||||||
| Registry Information | ||
| Official Title | Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients | |
| Trial Start Date | 2003-01-23 | |
| Registered in ClinicalTrials.gov | NCT00054223 | |
| Date Submitted to PDQ | 2002-12-23 | |
| Information Last Verified | 2006-09-28 | |
Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.
Back to Top

